Citadel Advisors’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.15M Sell
144,242
-470,572
-77% -$16.9M ﹤0.01% 4371
2026
Q1
$19.7M Buy
614,814
+166,114
+37% +$6.11M ﹤0.01% 2360
2025
Q4
$17.2M Buy
448,700
+74,665
+20% +$1.64M ﹤0.01% 2536
2025
Q3
$5.14M Buy
374,035
+19,572
+6% +$230K ﹤0.01% 4314
2025
Q2
$4.58M Buy
354,463
+293,393
+480% +$3.05M ﹤0.01% 4266
2025
Q1
$686K Sell
61,070
-158,808
-72% -$2.08M ﹤0.01% 7787
2024
Q4
$2.88M Buy
219,878
+57,265
+35% +$1.47M ﹤0.01% 4905
2024
Q3
$6.5M Sell
162,613
-690,163
-81% -$25.1M ﹤0.01% 3529
2024
Q2
$25.2M Buy
+852,776
New +$23.2M 0.01% 1764

Other funds holding PACS

Citadel Advisors's PACS Position: Q2 2026 in Review

Citadel Advisors reduced its PACS Group (PACS) stake by 77% in Q2 2026, selling an estimated $16.9M and leaving 144,242 shares worth $6.15M. The position accounts for ﹤0.01% of the portfolio, ranked #4371.

Citadel Advisors first reported a position in PACS in Q2 2024 and has held it in 9 quarters since. The position peaked at $25.2M in Q2 2024. 239 funds tracked by Wall St. Rank hold PACS as of Q2 2026.

  • Citadel Advisors held 144,242 shares of PACS Group worth $6.15M as of Q2 2026.
  • Citadel Advisors sold 470,572 PACS Group shares in Q2 2026, an estimated $16.9M.
  • PACS Group made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #4371 holding.
  • Citadel Advisors first reported a position in PACS Group in Q2 2024 and has held it in 9 quarters since.
  • Citadel Advisors's PACS Group position peaked at $25.2M in Q2 2024.
  • 239 funds tracked by Wall St. Rank held PACS Group as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.